Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) EBIT Margin: 2016-2025

Historic EBIT Margin for cbdMD (YCBD) over the last 9 years, with Sep 2025 value amounting to -14.53%.

  • cbdMD's EBIT Margin fell 758.00% to -14.53% in Q3 2025 from the same period last year, while for Sep 2025 it was -11.27%, marking a year-over-year increase of 537.00%. This contributed to the annual value of -11.27% for FY2025, which is 537.00% up from last year.
  • cbdMD's EBIT Margin amounted to -14.53% in Q3 2025, which was up 26.03% from -19.64% recorded in Q2 2025.
  • Over the past 5 years, cbdMD's EBIT Margin peaked at -1.69% during Q4 2024, and registered a low of -373.55% during Q2 2022.
  • In the last 3 years, cbdMD's EBIT Margin had a median value of -19.64% in 2025 and averaged -38.71%.
  • Per our database at Business Quant, cbdMD's EBIT Margin tumbled by 31,475bps in 2022 and then skyrocketed by 34,533bps in 2023.
  • cbdMD's EBIT Margin (Quarterly) stood at -255.10% in 2021, then surged by 19,027bps to -64.84% in 2022, then surged by 4,501bps to -19.83% in 2023, then soared by 1,814bps to -1.69% in 2024, then crashed by 758bps to -14.53% in 2025.
  • Its EBIT Margin stands at -14.53% for Q3 2025, versus -19.64% for Q2 2025 and -10.23% for Q1 2025.